Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Conagen Inc patents


Recent patent applications related to Conagen Inc. Conagen Inc is listed as an Agent/Assignee. Note: Conagen Inc may have other listings under different names/spellings. We're not affiliated with Conagen Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Conagen Inc-related inventors


Composition for preventing hair loss or promoting hair growth comprising extracellular follicle derived from lactic acid bacteria

The present specification discloses a composition for preventing hair loss or promoting hair growth comprising, as an active ingredient, extracellular follicles derived from lactic acid bacteria, and a method for preparing the extracellular follicles derived from lactic acid bacteria. The composition has an effect of preventing and prohibiting hair from falling off from the scalp or becoming thin or tapered. ... Conagen Inc

Keypad with replaceable key labels

A key able to accept a label for a keypad used in controlling electrically operated devices, wherein the key structure accepts and secures an interchangeable label, and which forms an impermeable barrier to the electrical contacts of a programmable circuit board.. . ... Conagen Inc

R-spondin agonist-mediated hair growth

Cosmetic skin and hair care compositions for enhancing the growth and appearance of mammalian hair in an individual are provided, which compositions comprise a dose of an r-spondin agonist effective to promote anagen phase of the hair cycle.. . ... Conagen Inc

Compositions and methods for the treatment or the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces

Compositions and methods for treating or preventing e. Coli infections are provided. ... Conagen Inc

Production of non-caloric sweeteners using engineered whole-cell catalysts

Disclosed are whole-cell catalysts, methods of making the whole-cell catalysts, and methods of using the whole-cell catalysts to produce steviol glycosides.. . ... Conagen Inc

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebausoside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebausoside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebausoside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebaudioside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

Non-caloric sweetener

Disclosed is a steviol glycoside referred to as rebaudioside d2. Rebaudioside d2 has five β-d-glucosyl units connected to the aglycone steviol. ... Conagen Inc

Non-caloric sweetener

Disclosed is a steviol glycoside referred to as rebaudioside d2. Rebaudioside d2 has five β-d-glucosyl units connected to the aglycone steviol. ... Conagen Inc

Non-caloric sweetener

Disclosed is a steviol glycoside referred to as rebaudioside d2. Rebaudioside d2 has five β-d-glucosyl units connected to the aglycone steviol. ... Conagen Inc

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebausoside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

Gold kiwifruit compositions and methods of preparation and use therefor

The present disclosure encompasses compositions prepared from kiwifruit. In particular, the invention encompasses compositions prepared from gold varieties of actinidia chinensis. ... Conagen Inc

11/02/17 / #20170312206

Method of treating a hair disorder with n-hydroxypyridinones

The present invention is directed to a method for treating a hair disorder in a human or animal in need thereof, involving topically applying to the human or animal an effective amount of at least one 6-substituted 2-pyridinol n-oxide compound, a tautomer, or a cosmetically acceptable salt thereof wherein a hair count is increased by at least 0.5 hairs/cm2 and/or an increase the number of anagen hairs and maintain the number of telogen hairs when compared to a baseline and/or vehicle.. . ... Conagen Inc

10/12/17 / #20170294279

Keypad with replaceable key labels

A key able to accept a label for a keypad used in controlling electrically operated devices, wherein the key structure accepts and secures an interchangeable label, and which forms an impermeable barrier to the electrical contacts of a programmable circuit board.. . ... Conagen Inc

08/17/17 / #20170233826

Mrna and/or protein of ercc1 isoform 3 for use in diagnosing a resistance against a therapeutic agent and method for diagnosing a resistance against a therapeutic agent using said mrna and/or protein

. . A method for diagnosing a resistance against a therapeutic agent in a patient, which includes measuring an amount of ercc1 isoform 3 protein and/or an amount of ercc1 isoform 3 mrna, which present in a liquid sample or a tissue sample obtained from the patient, and comparing the measured amount to a predetermined value, wherein an amount above the predetermined value indicates resistance against said therapeutic agent.. . ... Conagen Inc

08/17/17 / #20170233818

Multiple target nucleic acid detection method using clamping probe and detection probe

The present invention relates to an application of a target nucleic acid detection method using a clamping probe and a detection probe. The method of the present invention can effectively detect a small amount of variation or a specific gene sequence contained in a sample by selective amplification and detection of a trace amount of a target gene to be detected while inhibiting amplification of wild-type genes or undesired genes. ... Conagen Inc

08/03/17 / #20170218421

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebausoside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

08/03/17 / #20170218420

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebausoside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

07/13/17 / #20170198340

Method for the detection of multiple target nucleic acids using clamping probes and detection probes

Disclosed is a probe mixture for real-time detection of target nucleic acids comprising at least one detection probe and at least one clamping probe for inhibiting amplification of wild type genes or unwanted genes, a kit using the same and a method for real-time detection of target nucleic acids using the mixture and the kit.. . ... Conagen Inc

07/13/17 / #20170196248

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebausoside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

06/29/17 / #20170181452

Non-caloric sweeteners and methods for synthesizing

Disclosed are steviol glycosides referred to as rebaudioside v and rebaudioside w. Also disclosed are methods for producing rebaudioside m (reb m), rebausoside g (reb g), rebaudioside ka (reb ka), rebaudioside v (reb v) and rebaudioside (reb w).. ... Conagen Inc

03/23/17 / #20170081691

Recombinant production of steviol glycosides

Recombinant polypeptides having udp-glycosyltransferase activities, including a 1,2-19-o-glucose glycosylation activity and a 1,2-13-o-glucose glycosylation activity for synthesizing of steviol glucosides, are provided. A method of producing a steviol glycoside composition using such recombinant polypeptide is also provided. ... Conagen Inc

03/09/17 / #20170067092

Melting curve analysis using pna probe, method and kit for analyzing nucleotide polymorphism using melting curve analysis

Provided are a pna probe for detecting nucleotide polymorphism of a target gene, a melting curve analysis method for detecting the nucleotide polymorphism of the target gene using the same, a nucleotide polymorphism analysis method of a target gene including the melting curve analysis method, and a kit for detecting the nucleotide polymorphism of the target gene containing the pna probe. It is characterized that the pna probe according to the present invention contains negative charge molecules. ... Conagen Inc

03/02/17 / #20170059863

Display device, and display method therefor

This display device is provided with a display unit, a beam splitter, and a first mirror. The display unit emits a first image and a second image. ... Conagen Inc

02/23/17 / #20170051325

Microbial ergothioneine biosynthesis

Disclosed are methods for ergothioneine biosynthesis. More particularly, the present disclosure relates to methods for microbial ergothioneine biosynthesis. ... Conagen Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Conagen Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Conagen Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###